ClinicalTrials.Veeva

Menu

Accuracy of Scoring Systems for Risk Assessment in Neonatal Intensive Care Unit

S

Sohag University

Status

Enrolling

Conditions

Neonatal Death

Treatments

Other: nSOFA
Other: CRIB II
Other: SNAPPE-II
Other: STOPS
Other: MSNS
Other: SNAP-II

Study type

Observational

Funder types

Other

Identifiers

NCT05763316
Soh-Med-23-03-10MS

Details and patient eligibility

About

Early detection of neonates with higher risk of death is quite important for paying more attention to these cases, timely referral to tertiary neonatal intensive care unit (NICU), and provision of meticulous critical care, which ultimately may improve outcomes. Several scoring systems have recently been developed for assessment of the intensity of illness and prognosticate the risk of not only neonatal mortality but also short- and long-term morbidities. The accuracy of these scoring systems has been investigated in several NICUs from different countries, such as USA, UK, Canada, Brazil, India, and Iran. Previous Egyptian studies have investigated the accuracy of Clinical Risk Index for Babies II (CRIB II), Score for Neonatal Acute Physiology II (SNAP-II) and its Perinatal Extension II (SNAPPE-II). However, the accuracy of Sensorium, temperature, oxygenation, perfusion, skin color, and blood sugar (STOPS), Modified Sick neonatal Score (MSNS), and neonatal sequential organ failure assessment (nSOFA) has not been investigated in Egyptian NICUs. Therefore, more studies are required to investigate the utility and accuracy of neonatal risk assessment scores in Egyptian NICUs.

Enrollment

300 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission within 24 hours after birth.
  • Length of hospital stay at the first admission to NICU ≥12 hours

Exclusion criteria

  • Major congenital anomalies.
  • Discharge against medical advice
  • Transportation to other places.
  • Missing data on items of scoring systems

Trial design

300 participants in 1 patient group

Study participants
Description:
Neonates admitted to NICU and fulfilling eligibility criteria
Treatment:
Other: MSNS
Other: CRIB II
Other: STOPS
Other: SNAP-II
Other: SNAPPE-II
Other: nSOFA

Trial contacts and locations

1

Loading...

Central trial contact

Elsayed Abdelkreem, MD, PhD; Rehab Z Abdelftah, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems